An experimental dengue fever vaccine appears to be closer than ever to gaining approval for human use. According to the results of a large clinical trial — the third such trial the vaccine has undergone — receiving three doses of the vaccine reduces the overall risk of becoming infected with the tropical mosquito-borne disease by 60 percent. Moreover, the drug appears to be 95.5 percent protective against the most severe form of the disease, dengue hemorrhagic fever, which means that a widely-adopted vaccine could one day make a big dent in the number of dengue-related hospitalizations worldwide.
via The Verge - All Posts http://ift.tt/1obwRRL
No comments:
Post a Comment